Retrospective cohort study compares medication order changes linked to real-time benefit tool redesign in primary care, suggesting effective communication improves outcomes.
Key Points
To assess the impact of redesigning real-time benefit tools from user-directed to interruptive on medication order change frequencies and display rates.
Retrospective cohort study using electronic health record data from Duke Health between January 2022 and December 2023.
Participants included adults with multimorbidity prescribed at least one medication with display capability.
Generalized linear models were used to analyze changes in tool display frequency and medication order changes.
RTBT display frequency increased significantly from 1.3% in 2022 to 13.5% in 2023.
Interruptive design was associated with an increase in RTBT display frequency (RR, 9.62; 95% CI, 8.16-11.35) and in medication changes (RR, 8.37; 95% CI, 7.08-9.91).
No significant change in medication order changes per displayed RTBT was observed (RR, 0.93; 95% CI, 0.84-1.04).